Skip to search formSkip to main contentSkip to account menu

PX 13

Known as: PX-13 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Alkanesulfonates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Nanostructured lipid carriers as delivery system for the phopholipase A2 inhibitors PX-18 and PX-13 for dermal application.
PX-18 and PX-13 are secretory phospholipase A2-IIA (sPLA2-IIA) inhibitors. An increased expression of sPLA2 in psoriatic skin has… 
2011
2011
Sub:- Safeguard investigation concerning imports of N1,3-tldimeyl butyl-N Penylenediamine (PX-13 also known as 6PPD)- Corrigendum to Initiation Notice regarding.
1999
1999
Secretory event in intestinal grafts during preservation ischemia.
BACKGROUND Ischemia triggers secretion of proteins from the intestine, including type II secretory phospholipase A2 (sPLA2). This… 
1997
1997
Phospholipase A2 Secretion During Intestinal Graft Ischemia
The time-dependent appearance of phospholipaseA2 (PLA2) activity in thepreservation media of ischemic rat intestinal grafts… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)